David L. Spector

Brigham and Women's Hospital

Full Professor(heuristic)

RNA Research and Splicing · Molecular Biology

h-index92

i10-index162

Publications361

Citations39,383

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 74

Supplementary Figure S2 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S2 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Figure S1 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S4 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S1 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Figure Legends from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S5 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Data from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S3 from <i>LINC01235</i> Is an Upstream Regulator of the <i>NFIB</i> Gene and the Notch Pathway in Triple-Negative Breast Cancer
2026-06-19
Supplementary Table S7 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S9 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Table S1 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S2 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S3 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Table S6 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S4 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S5 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Figure S1 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Table S4 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17
Supplementary Table S9 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
2026-06-17

Open author page on OpenAlex →